Elevance Health Stock Forecast for 2023 - 2025 - 2030
Updated on 02/05/2023
Elevance Health Stock Forecast and Price Target
Elevance Health's stock price reaches the average target of $580.00 by 2024 as expected recently by two notable experts, there would be a potential upside of approximately 21.41% from the last closing price in February, 2023. This possible increase is based on a high estimate of $620.00 and a low estimate of $400.00. If you are not interested in ELV stock, you may be interested in its competitors.
21.41% Upside
Elevance Health Fair Value Forecast for 2023 - 2025 - 2030
In the last two years, Elevance Health's Price has grown, increasing from $284.02 to $379.57 – a growth of 33.64%. The next year looks promising for Elevance Health, with analysts predicting Fair Value of $473.51 – an increase of 24.75%. Over the next eight years, experts anticipate that Elevance Health's Fair Value will grow at a rate of 145.77%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| UNH Stock Forecast | UnitedHealth Group Inc | Outperform |
16
|
$472.02 | $584.04 | 26.27% |
| CI Stock Forecast | Cigna Corp | Outperform |
12
|
$292.59 | $359.82 | 23.04% |
| HUM Stock Forecast | Humana Inc | Outperform |
15
|
$476.57 | $611.23 | 30.10% |
| MOH Stock Forecast | Molina Healthcare | Outperform |
16
|
$301.07 | $341.36 | 24.22% |
| TRUP Stock Forecast | Trupanion | Outperform |
8
|
$65.07 | $118.60 | 46.00% |
Elevance Health Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Elevance Health's Revenue has grown, increasing from $104.21B to $138.64B – a growth of 33.04%. The next year looks promising for Elevance Health, with analysts predicting Revenue of $161.56B – an increase of 16.53%. Over the next eight years, experts anticipate that Elevance Health's Revenue will grow at a rate of 54.27%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| GTS Stock Forecast | Triple-S Management | - |
7
|
$35.98 | $19.00 | -80.04% |
| NDEV Stock Forecast | Novus Acquisition & Developmen... | - |
0
|
$0.04 | $0.00 | -100.00% |
| MRDH Stock Forecast | Meridian Holdings | - |
0
|
$0.06 | $0.00 | -100.00% |
Elevance Health Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Elevance Health's Dividend per Share has grown by 41.25%, from $3.20 to $4.52. For the next year, analysts are expecting Dividend per Share to reach $4.96 – an increase of 9.73%. Over the next eight years, experts predict that Dividend per Share will grow by 154.20%.
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|
| DPAT Stock Forecast | Dental Patient Care America | - |
0
|
$0.03 | $0.00 | -100.00% |
| CHCR Stock Forecast | Advanzeon Solutions | - |
-18
|
$0.00 | $0.00 | 0.00% |
| CNC Stock Forecast | Centene Corp | Outperform |
12
|
$77.04 | $98.72 | 29.80% |
Elevance Health Free Cash Flow Forecast for 2023 - 2025 - 2030
In the last two years, Elevance Health's Free Cash Flow has grown by 46.01%, rising from $4.98B to $7.28B. In the following year, the 3 analysts surveyed believe that Elevance Health's Free Cash Flow will decrease by 2.51%, reaching $7.09B. Over the next eight years, experts predict that Elevance Health's Free Cash Flow will grow at a rate of 49.03%.
Elevance Health Net Income Forecast for 2023 - 2025 - 2030
In the last two years, Elevance Health's Net Income has grown from $4.81B to $6.10B – a 26.98% increase. Next year, analysts are expecting Net Income to reach $7.78B – an increase of 27.44%. Over the next eight years, the forecast is for Net Income to grow by 95.17%.
Elevance Health EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Elevance Health's EBITDA has grown by 33.98%, rising from $7.30B to $9.77B. For next year, analysts predict EBITDA of $12.19B, which would mean an increase of 24.67%. Over the next eight years, experts predict that Elevance Health's EBITDA will grow at a rate of 81.55%.
Elevance Health EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Elevance Health's EBIT has grown, rising from $6.73B to $8.96B – a growth of 33.05%. In the next year, analysts believe that EBIT will reach $10.89B – an increase of 21.58%. For the next eight years, the forecast is for EBIT to grow by 46.89%.
Elevance Health EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last two years, Elevance Health's EPS has grown, increasing from $19.44 to $25.98 – a growth of 33.64%. The next year looks promising for Elevance Health, with analysts predicting EPS of $32.41 – an increase of 24.75%. Over the next eight years, experts anticipate that Elevance Health's EPS will grow at a rate of 145.77%.